High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 106, Issue 5, Pages 592-597
Publisher
Wiley
Online
2015-02-21
DOI
10.1111/cas.12638
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting IL-11 signaling in colon cancer
- (2015) Matthias Ernst et al. Oncotarget
- Prognostic Value of Diametrically Polarized Tumor-Associated Macrophages in Renal Cell Carcinoma
- (2014) Le Xu et al. ANNALS OF SURGICAL ONCOLOGY
- Molecular Pathways: IL11 as a Tumor-Promoting Cytokine--Translational Implications for Cancers
- (2014) M. Ernst et al. CLINICAL CANCER RESEARCH
- IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
- (2014) Koji Taniguchi et al. SEMINARS IN IMMUNOLOGY
- Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
- (2013) Tracy L. Putoczki et al. CANCER CELL
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Novel Immunotherapeutic Strategies in Development for Renal Cell Carcinoma
- (2012) Brant A. Inman et al. EUROPEAN UROLOGY
- Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
- (2012) Hai T Tran et al. LANCET ONCOLOGY
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
- (2010) J-F Rossi et al. BRITISH JOURNAL OF CANCER
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- Presence of Intratumoral Neutrophils Is an Independent Prognostic Factor in Localized Renal Cell Carcinoma
- (2009) Hanne Krogh Jensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma
- (2008) Jacob A. Klapper et al. CANCER
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
- (2008) Kiran Gupta et al. CANCER TREATMENT REVIEWS
- Cytokines as a key component of cancer-related inflammation
- (2008) Giovanni Germano et al. CYTOKINE
- The Interleukin-6 Family Cytokine Interleukin-11 Regulates Homeostatic Epithelial Cell Turnover and Promotes Gastric Tumor Development
- (2008) Meegan Howlett et al. GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started